Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	ATP5PF SETX CFTR DDX42 NAIP PEX1 SRPRA SRCAP ABCG4 KCNJ8 KIFC3 TAP2 KIFC1 HSP90AB1 TTF2 SMCHD1 ABCB5 INO80 ATAD2 KIFC2 DHX30 ABCA6 IGHMBP2 ABCB8	1.19e-07	614	224	24	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	ATP5PF CFTR DDX42 NAIP PEX1 SRPRA SRCAP ABCG4 TAP2 KIFC1 HSP90AB1 SMCHD1 ABCB5 INO80 ATAD2 KIFC2 DHX30 ABCA6 IGHMBP2 ABCB8	1.37e-07	441	224	20	GO:0016887
GeneOntologyMolecularFunction	ABC-type transporter activity	CFTR ABCG4 TAP2 ABCB5 ABCA6 ABCB8	1.74e-05	49	224	6	GO:0140359
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	ATP5PF CFTR DDX42 NAIP PEX1 SRPRA SRCAP ABCG4 TAP2 KIFC1 HSP90AB1 REM1 SMCHD1 ABCB5 INO80 ATAD2 KIFC2 ARL4D DHX30 ABCA6 IGHMBP2 ABCB8	6.46e-05	775	224	22	GO:0017111
GeneOntologyMolecularFunction	pyrophosphatase activity	ATP5PF CFTR DDX42 NAIP PEX1 SRPRA SRCAP ABCG4 TAP2 KIFC1 HSP90AB1 REM1 SMCHD1 ABCB5 INO80 ATAD2 KIFC2 ARL4D DHX30 ABCA6 IGHMBP2 ABCB8 FITM1	7.43e-05	839	224	23	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	ATP5PF CFTR DDX42 NAIP PEX1 SRPRA SRCAP ABCG4 TAP2 KIFC1 HSP90AB1 REM1 SMCHD1 ABCB5 INO80 ATAD2 KIFC2 ARL4D DHX30 ABCA6 IGHMBP2 ABCB8 FITM1	7.57e-05	840	224	23	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	ATP5PF CFTR DDX42 NAIP PEX1 SRPRA SRCAP ABCG4 TAP2 KIFC1 HSP90AB1 REM1 SMCHD1 ABCB5 INO80 ATAD2 KIFC2 ARL4D DHX30 ABCA6 IGHMBP2 ABCB8 FITM1	7.57e-05	840	224	23	GO:0016818
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	CFTR ABCG4 KCNJ8 TAP2 ABCB5 ABCA6 ABCB8	2.30e-04	109	224	7	GO:0042626
GeneOntologyMolecularFunction	sulfonylurea receptor binding	KCNJ8 HSP90AB1	3.73e-04	3	224	2	GO:0017098
GeneOntologyMolecularFunction	ABC-type peptide transporter activity	TAP2 ABCB8	7.41e-04	4	224	2	GO:0015440
GeneOntologyMolecularFunction	receptor ligand inhibitor activity	LRRC32 HSP90AB1	7.41e-04	4	224	2	GO:0141069
GeneOntologyMolecularFunction	very-low-density lipoprotein particle receptor binding	PCSK9 APOE	7.41e-04	4	224	2	GO:0070326
HumanPheno	Abnormality of the musculature of the upper limbs	MARS1 SPEG SPTAN1 RPS7 RPS20 HMGCR CUL7 SYNE2 FBXW11 VPS37A COL13A1 SMCHD1 CRPPA ALS2 REV3L IDUA GYG1	2.91e-06	283	85	17	HP:0001446
Domain	AAA	CFTR NAIP PEX1 SRPRA ABCG4 TAP2 ABCB5 ATAD2 ABCA6 IGHMBP2 ABCB8	1.52e-06	144	227	11	SM00382
Domain	AAA+_ATPase	CFTR NAIP PEX1 SRPRA ABCG4 TAP2 ABCB5 ATAD2 ABCA6 IGHMBP2 ABCB8	1.52e-06	144	227	11	IPR003593
Domain	ABC_tran	CFTR ABCG4 TAP2 ABCB5 ABCA6 ABCB8	2.42e-05	48	227	6	PF00005
Domain	ABC_TRANSPORTER_2	CFTR ABCG4 TAP2 ABCB5 ABCA6 ABCB8	2.42e-05	48	227	6	PS50893
Domain	ABC_TRANSPORTER_1	CFTR ABCG4 TAP2 ABCB5 ABCA6 ABCB8	2.73e-05	49	227	6	PS00211
Domain	ABC_transporter-like	CFTR ABCG4 TAP2 ABCB5 ABCA6 ABCB8	3.07e-05	50	227	6	IPR003439
Domain	P-loop_NTPase	SETX CFTR DDX42 NAIP PEX1 SRPRA SRCAP ABCG4 KIFC3 CHST2 MYO18B TAP2 KIFC1 TTF2 REM1 ABCB5 INO80 ATAD2 KIFC2 ARL4D DHX30 ABCA6 IGHMBP2 ABCB8 COASY	4.01e-05	848	227	25	IPR027417
Domain	Beta-TrCP_D	BTRC FBXW11	1.47e-04	2	227	2	IPR021977
Domain	Beta-TrCP_D	BTRC FBXW11	1.47e-04	2	227	2	PF12125
Domain	Beta-TrCP_D	BTRC FBXW11	1.47e-04	2	227	2	SM01028
Domain	ABC_transporter_CS	CFTR ABCG4 TAP2 ABCB5 ABCB8	1.50e-04	42	227	5	IPR017871
Domain	ABC_membrane	CFTR TAP2 ABCB5 ABCB8	1.87e-04	24	227	4	PF00664
Domain	-	SETX CFTR DDX42 NAIP PEX1 SRPRA SRCAP ABCG4 CHST2 TAP2 TTF2 REM1 ABCB5 INO80 ATAD2 ARL4D DHX30 ABCA6 IGHMBP2 ABCB8 COASY	3.17e-04	746	227	21	3.40.50.300
Domain	ABC_TM1F	CFTR TAP2 ABCB5 ABCB8	3.46e-04	28	227	4	PS50929
Domain	ABC1_TM_dom	CFTR TAP2 ABCB5 ABCB8	3.46e-04	28	227	4	IPR011527
Domain	FBOX	FBXL12 FBXW8 BTRC FBXW11 FBXL15	4.14e-04	52	227	5	SM00256
Pathway	KEGG_ABC_TRANSPORTERS	CFTR ABCG4 TAP2 ABCB5 ABCA6 ABCB8	1.50e-05	44	173	6	M11911
Pathway	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	FBXL12 PSMD3 CUL7 TLR6 UBE4A FBXW8 ERAP2 ANAPC2 LNX1 TAP2 BTRC FBXW11 NPEPPS FBXL15 ATG14 LRR1	1.87e-05	381	173	16	M1066
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ERBB2 EPPK1 SPEG FBXL12 CBLC SRCAP PCNX2 TULP4 XPO6 MTMR3 PDZD8 CACNA1H KIFC3 RGL2 FEM1A IQCE PITPNM2 TEAD2 MYOM3 INO80 REV3L IDUA DLL1 KIFC2 DHX30 RPAP1 DIP2C PDCD11 WDFY3 PCNT PPP1R16A	1.23e-11	1105	229	31	35748872
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	SNX4 STXBP4 SPTAN1 RPS7 FBXL12 PSMD3 SRPRA CBARP CUL7 SLC30A1 DUSP26 PTPN3 BSG SYNE2 MTMR3 PPP1R37 ALDH18A1 PDZD8 NHS BTRC FBXW11 HSP90AB1 POLR2B PPP4C PPP6C PCNT	8.20e-09	1049	229	26	27880917
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SNPH IFT172 SPEG ADAM9 ADCY6 PXDN MTMR3 CACNA1H WHRN ALS2 DHX30 RPAP1 SIPA1L1 LRRTM2 TRAK2 PCNT	1.53e-08	407	229	16	12693553
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CNKSR1 IFT172 ADAM9 SPTAN1 TTLL5 ANKRD49 UBE4A MTMR3 PDZD8 KIFC3 LNX1 BTRC FBXW11 ARMC8 HSP90AB1 SETMAR CNTNAP1 REV3L APOE DALRD3 DHX30 FRY SIPA1L1 MRPS9 ZNF350 WDFY3 DNAI7 PCNT	3.28e-08	1285	229	28	35914814
Pubmed	Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort.	HMGCR PCSK9 APOE	2.82e-07	3	229	3	20031582
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ATP5PF STXBP4 SPTAN1 TTLL5 DDX42 SRPRA CBARP SSBP1 HSPA12B SLC30A1 UBE4A ERAP2 BSG SYNE2 PDZD8 WDR62 POLR2B DHX30 PAXBP1 RPAP1 PPP6C MAP4K5 DHRS7 PHACTR4 MRPS9 PDCD11 COASY PCNT	6.39e-07	1487	229	28	33957083
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MARS1 SPTAN1 RPS7 DDX42 PSMD3 RPS20 SSBP1 NUP205 UBE4A BSG PRDX3 ALDH18A1 CHST2 MYO18B MED23 KIFC1 ARMC8 HSP90AB1 NPEPPS SMCHD1 POLR2B ATAD2 DHX30 PAXBP1 MRPS9 PDCD11 COASY	9.15e-07	1425	229	27	30948266
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ATP5PF SCN11A PDGFA SPTAN1 RPS7 DDX42 PSMD3 SRCAP ADCY6 NUP205 PXDN BSG SYNE2 DLEC1 ZNF541 HSP90AB1 CACNA1E DRD5 ZNF474 SMCHD1 ABCB5 AVIL MRPS9 SMARCD2 CEP295 ZNF350 PCNT	1.15e-06	1442	229	27	35575683
Pubmed	Functional genomic landscape of cancer-intrinsic evasion of killing by T cells.	ANKRD49 PEX1 SRCAP TAS2R4 PI4KB MED23 TAP2 FBXW11 VPS37A BCL2L10 ATG14 WDR97 SMARCD2 PCNT	2.41e-06	457	229	14	32968282
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	ATP5PF MARS1 SPTAN1 PSMD3 SRPRA HMGCR SSBP1 NUP205 UBE4A PXDN BSG PRDX3 SYNE2 ALDH18A1 TAP2 BTRC FBXW11 ARMC8 NPEPPS POLR2B SPAG5 PPP4C PPP6C SIPA1L1 MRPS9 PDCD11	3.54e-06	1440	229	26	30833792
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	SNPH IFT172 SPTAN1 PLCB3 BTRC FBXW11 PITPNM2 CACNA1E SMCHD1 INO80 DHX30 FRY SIPA1L1 SMARCD2	3.76e-06	475	229	14	31040226
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	SETX CUL7 EMSY NUP205 TCF24 XYLT1 HOXA10 UBE4A PHKG2 HOXB9 FBXW8 BTRC FBXW11 ARMC8 HSP90AB1 TTF2 TEAD2 ZBTB2 REV3L	4.69e-06	857	229	19	25609649
Pubmed	Co-operative binding of SKP1, Cullin1 and Cullin7 to FBXW8 results in Cullin1-SKP1-FBXW8-Cullin7 functional complex formation that monitors cellular function of β-TrCP1.	CUL7 FBXW8 BTRC	5.55e-06	6	229	3	34478796
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	SETX LAMA1 EVPL SRPRA RPS20 NUP205 ALDH18A1 PLCB3 IQCE HSP90AB1 REM1 MYOM3 REV3L FRY RPAP1 CEP295 CFAP44	8.90e-06	736	229	17	29676528
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	ATP5PF IFT172 SPTAN1 PSMD3 RPS20 SSBP1 EMSY DUSP26 CACNA1H HSP90AB1 WHRN SETMAR SMCHD1 TRAK2	9.00e-06	513	229	14	25798074
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	STXBP4 SPTAN1 SRPRA CUL7 PI4KB MTMR3 ALDH18A1 WDR62 EIF4E2 TTF2 PPP6C SIPA1L1 CEP295	9.44e-06	446	229	13	24255178
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	MARS1 SPTAN1 RPS7 PSMD3 RPS20 HOXB9 TULP4 ERAP2 BSG PRDX3 ALDH18A1 NHS FBXW11 HSP90AB1 NPEPPS POLR2B APOE DHX30 PAXBP1 PPP6C CTCF IGHMBP2 SIPA1L1	9.55e-06	1247	229	23	27684187
Pubmed	The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1.	CUL7 FBXW8 PPP4C	9.67e-06	7	229	3	24362026
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	SETX MARS1 STXBP4 DDX42 ANKRD49 PEX1 SRCAP KCNJ8 RNASEH2C ARMC8 POLR2B MARCHF7 ALS2 INO80 KIFC2 SPAG5 PAXBP1 PPP6C SIPA1L1 CEP295 PCNT	1.15e-05	1084	229	21	11544199
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SETX MARS1 SPTAN1 RPS7 PSMD3 RPS20 SSBP1 SRCAP NUP205 IQSEC1 PPP1R37 ALDH18A1 BTRC HSP90AB1 TTF2 NPEPPS SMCHD1 POLR2B ATAD2 DHX30 PPP6C MAP4K5 PDCD11 WDFY3	1.15e-05	1353	229	24	29467282
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	SPEG LRRC32 RPS7 DDX42 SRPRA RPS20 SSBP1 SLC30A1 XYLT1 NEU2 BSG PRDX3 IQSEC1 ALDH18A1 PDZD8 KIFC3 TAP2 HSP90AB1 MAN2B2 CNTNAP1 PPP4C CRACDL DHRS7 OXNAD1 CFAP44	1.23e-05	1451	229	25	30550785
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	MARS1 RPS7 DDX42 EVPL RPS20 SSBP1 PRDX3 ALDH18A1 WDR62 EIF4E2 GEMIN2 INO80 ATAD2 DHX30 PAXBP1 CTCF MRPS9 PDCD11	1.48e-05	847	229	18	35850772
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	MARS1 RPS7 PSMD3 RPS20 NUP205 FBXW8 PXDN BSG HSP90AB1 MAN2B2 NPEPPS SMCHD1 POLR2B CNTNAP1 PPP6C	1.56e-05	613	229	15	22268729
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SNX4 STXBP4 TTLL5 RPS7 SSBP1 EMSY NUP205 WDR62 HSP90AB1 EIF4E2 TTF2 POLR2B SPAG5 PPP6C SIPA1L1 PHACTR4 CEP295 PCNT	1.63e-05	853	229	18	28718761
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	EPPK1 MARS1 DDX42 PSMD3 CUL7 SRCAP NUP205 FBXW8 PRDX3 SYNE2 KIFC1 HSP90AB1 GEMIN2 NPEPPS SMCHD1 POLR2B DHX30 RPAP1 PDCD11 PCNT	1.67e-05	1024	229	20	24711643
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	SNX4 CHST14 MARS1 ADAM9 PEX1 SRPRA NUP205 PXDN BSG XPO6 ANAPC2 HSP90AB1 TTF2 POLR2B MARCHF7 SPAG5 RPAP1 PPP6C DHRS7	1.76e-05	942	229	19	31073040
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ERBB2 SETX STXBP4 SPTAN1 RPS7 CBARP PTPN3 PI4KB SYNE2 OSBPL6 IQSEC1 NHS RGL2 WDR62 EIF4E2 ALS2 SIPA1L1 PHACTR4	1.84e-05	861	229	18	36931259
Pubmed	The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.	NAIP SRCAP PXDN ANAPC2 MOS SMCHD1 POLR2B ASTE1 SPAG5 MRPS9	1.92e-05	281	229	10	24163370
Pubmed	Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system.	FBXL12 FBXW8 BTRC FBXW11 UBD FBXL15	2.16e-05	85	229	6	19028597
Pubmed	Identification of genetic variants associated with response to statin therapy.	HMGCR PCSK9 APOE	2.30e-05	9	229	3	19667110
Pubmed	Polymorphisms associated with cholesterol and risk of cardiovascular events.	HMGCR PCSK9 APOE	2.30e-05	9	229	3	18354102
Pubmed	A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in women.	HMGCR PCSK9 APOE	2.30e-05	9	229	3	19773416
Pubmed	Disruption of axo-glial junctions causes cytoskeletal disorganization and degeneration of Purkinje neuron axons.	SPTAN1 CCR10 CNTNAP1	2.30e-05	9	229	3	16551741
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ADAM9 SPTAN1 WDR81 EMSY CNTNAP5 SYNE2 IQSEC1 ARMC8 HSP90AB1 TRIM46 CACNA1E NPEPPS CNTNAP1 FRY PPP6C CTCF SIPA1L1 WDFY3 PCNT	2.38e-05	963	229	19	28671696
Pubmed	Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro.	ADCY6 PCNX2 SIPA1L1 LRRTM2 PCNT	2.39e-05	52	229	5	9455477
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	HSPA12B SLC30A1 PCNX2 IQSEC1 IQCE WHRN CACNA1E PHACTR4 CEP295	2.65e-05	233	229	9	37704626
Pubmed	Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss.	IFT172 ADAM9 TTLL5 WDR81 PEX1 CXCR5 BSG SYNE2 WHRN	2.65e-05	233	229	9	32290105
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	POP7 MARS1 SPEG RPS7 PSMD3 SRPRA RPS20 SSBP1 ANAPC2 KIFC1 HSP90AB1 TTF2 SMCHD1 POLR2B PCDHAC1 DHX30 PPP6C MRPS9 PDCD11	2.66e-05	971	229	19	33306668
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	STX2 ATP5PF ERBB2 CHST14 ADAM9 SRPRA HMGCR SSBP1 SLC30A1 ADCY6 NUP205 SGCE TMEM221 NPEPPS SMCHD1 SCARA5 DHRS7 ABCB8 C15orf61 WDFY3	2.75e-05	1061	229	20	33845483
Pubmed	Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.	POP7 ATP5PF ERBB2 ADAM9 PSMD3 SRPRA ADCY6 SCNM1 BSG LNX1 TAP2 TEAD2 CNTNAP1	3.05e-05	499	229	13	22810586
Pubmed	Systemwide disassembly and assembly of SCF ubiquitin ligase complexes.	FBXL12 FBXW8 BTRC FBXW11 FBXL15	3.15e-05	55	229	5	37028429
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	EPPK1 SPTAN1 RPS7 DDX42 CUL7 NUP205 SYNE2 ALDH18A1 NPEPPS SMCHD1 ATAD2 DHX30 CTCF PDCD11 PCNT	3.23e-05	653	229	15	22586326
Pubmed	Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.	GMPR PCSK9 APOE	3.27e-05	10	229	3	22331829
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	EPPK1 MARS1 SPTAN1 RPS7 PSMD3 EVPL SRPRA RPS20 SSBP1 NUP205 PTPN3 BSG ALDH18A1 KIFC1 HSP90AB1 SMCHD1 POLR2B DHX30 SIPA1L1 MRPS9 PDCD11 SMARCD2	3.32e-05	1257	229	22	36526897
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	EPPK1 RPS7 RPS20 NUP205 HOXA10 HOXB9 KIFC1 HSP90AB1 TTF2 SMCHD1 POLR2B PPP6C CTCF PDCD11	3.68e-05	583	229	14	29844126
Pubmed	No effect of genetic deletion of contactin-associated protein (CASPR) on axonal orientation and synaptic plasticity.	CCR10 CNTNAP1	4.32e-05	2	229	2	17549747
Pubmed	Control of ATG14 solubility and autophagy by MARCHF7/MARCH7-mediated ubiquitination.	MARCHF7 ATG14	4.32e-05	2	229	2	37915253
Pubmed	Gender specific hippocampal whole genome transcriptome data from mice lacking the Cav2.3 R-type or Cav3.2 T-type voltage-gated calcium channel.	CACNA1H CACNA1E	4.32e-05	2	229	2	28393090
Pubmed	Coding variants in the PCNT and CEP295 genes contribute to breast cancer risk in Chinese women.	CEP295 PCNT	4.32e-05	2	229	2	34418690
Pubmed	Mutually exclusive antiproliferative effect of cell line-specific HOX inhibition in epithelial ovarian cancer cell lines: SKOV-3 vs RMUG-S.	HOXA10 HOXB9	4.32e-05	2	229	2	31970886
Pubmed	Functional analyses of Pericentrin and Syne-2 interaction in ciliogenesis.	SYNE2 PCNT	4.32e-05	2	229	2	30054381
Pubmed	Evidence for a regulatory role of Cullin-RING E3 ubiquitin ligase 7 in insulin signaling.	CUL7 FBXW8	4.32e-05	2	229	2	24219910
Pubmed	Proteomic interaction profiling reveals KIFC1 as a factor involved in early targeting of F508del-CFTR to degradation.	CFTR KIFC1	4.32e-05	2	229	2	30066085
Pubmed	Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma.	ERBB2 IQSEC1	4.32e-05	2	229	2	21966491
Pubmed	A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers.	TAP2 APOE	4.32e-05	2	229	2	16595160
Pubmed	Ticagrelor suppresses oxidized low‑density lipoprotein‑induced endothelial cell apoptosis and alleviates atherosclerosis in ApoE‑/‑ mice via downregulation of PCSK9.	PCSK9 APOE	4.32e-05	2	229	2	30592271
Pubmed	The characteristics and roles of β-TrCP1/2 in carcinogenesis.	BTRC FBXW11	4.32e-05	2	229	2	33021036
Pubmed	Two separate Ni(2+) -sensitive voltage-gated Ca(2+) channels modulate transretinal signalling in the isolated murine retina.	CACNA1H CACNA1E	4.32e-05	2	229	2	21883984
Pubmed	Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin.	CCR10 CNTNAP1	4.32e-05	2	229	2	11395000
Pubmed	Mutations in CNTNAP1 and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects.	ADCY6 CNTNAP1	4.32e-05	2	229	2	24319099
Pubmed	Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion.	EIF4E2 CDH22	4.32e-05	2	229	2	28991229
Pubmed	Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression.	CFTR NHS	4.32e-05	2	229	2	14595111
Pubmed	Silencing FAT10 inhibits metastasis of osteosarcoma.	HOXB9 UBD	4.32e-05	2	229	2	27279480
Pubmed	Specificity, location and function of βTrCP isoforms and their splice variants.	BTRC FBXW11	4.32e-05	2	229	2	21138764
Pubmed	Proteasome 26S Subunit, non-ATPase 3 (PSMD3) Regulates Breast Cancer by Stabilizing HER2 from Degradation.	ERBB2 PSMD3	4.32e-05	2	229	2	31013812
Pubmed	HMGCR and ApoE mutations may cause different responses to lipid lowering statin therapy.	HMGCR APOE	4.32e-05	2	229	2	29096742
Pubmed	CTCF negatively regulates HOXA10 expression in breast cancer cells.	HOXA10 CTCF	4.32e-05	2	229	2	26478432
Pubmed	Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.	HMGCR PCSK9	4.32e-05	2	229	2	27959767
Pubmed	The C11orf30-LRRC32 region is associated with total serum IgE levels in asthmatic patients.	LRRC32 EMSY	4.32e-05	2	229	2	22070912
Pubmed	Functional blockage of EMMPRIN ameliorates atherosclerosis in apolipoprotein E-deficient mice.	BSG APOE	4.32e-05	2	229	2	23642811
Pubmed	Paranodal interactions regulate expression of sodium channel subtypes and provide a diffusion barrier for the node of Ranvier.	CCR10 CNTNAP1	4.32e-05	2	229	2	12904461
Pubmed	Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles.	PCSK9 APOE	4.32e-05	2	229	2	19619878
Pubmed	Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study.	HMGCR PCSK9	4.32e-05	2	229	2	28438747
Pubmed	Genetic variants of the C11orf30-LRRC32 region are associated with childhood asthma in the Chinese population.	LRRC32 EMSY	4.32e-05	2	229	2	31812328
Pubmed	Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.	PCSK9 APOE	4.32e-05	2	229	2	28546220
Pubmed	Combined PCSK9 and APOE polymorphisms are genetic risk factors associated with elevated plasma lipid levels in a Thai population.	PCSK9 APOE	4.32e-05	2	229	2	25899039
Pubmed	Non-Mendelian inheritance during inbreeding of Cav3.2 and Cav2.3 deficient mice.	CACNA1H CACNA1E	4.32e-05	2	229	2	33009476
Pubmed	Regional distribution and metabolic effect of PCSK9 insLEU and R46L gene mutations and apoE genotype.	PCSK9 APOE	4.32e-05	2	229	2	23743349
Pubmed	Exploring the methylation status of CFTR and PKIA genes as potential biomarkers for lung adenocarcinoma.	CFTR PKIA	4.32e-05	2	229	2	37644544
Pubmed	A functional polymorphism in the HMGCR promoter affects transcriptional activity but not the risk for Alzheimer disease in Swedish populations.	HMGCR APOE	4.32e-05	2	229	2	20450896
Pubmed	CFTR protects against vascular inflammation and atherogenesis in apolipoprotein E-deficient mice.	CFTR APOE	4.32e-05	2	229	2	28615349
Pubmed	The septate junction protein caspr is required for structural support and retention of KCNQ4 at calyceal synapses of vestibular hair cells.	CCR10 CNTNAP1	4.32e-05	2	229	2	19279247
Pubmed	PCSK9 aggravated carotid artery stenosis in ApoE-/- mice by promoting the expression of tissue factors in endothelial cells via the TLR4/NF-κB pathway.	PCSK9 APOE	4.32e-05	2	229	2	38797271
Pubmed	Cullin 7 and Fbxw 8 expression in trophoblastic cells is regulated via oxygen tension: implications for intrauterine growth restriction?	CUL7 FBXW8	4.32e-05	2	229	2	22524683
Pubmed	Differential dysregulation of β-TrCP1 and -2 by HIV-1 Vpu leads to inhibition of canonical and non-canonical NF-κB pathways in infected cells.	BTRC FBXW11	4.32e-05	2	229	2	37341489
Pubmed	Circulating PCSK9 is a strong determinant of plasma triacylglycerols and total cholesterol in homozygous carriers of apolipoprotein ε2.	PCSK9 APOE	4.32e-05	2	229	2	24308640
Pubmed	LNX1 is a perisynaptic Schwann cell specific E3 ubiquitin ligase that interacts with ErbB2.	ERBB2 LNX1	4.32e-05	2	229	2	16122940
Pubmed	Self-association of human PCSK9 correlates with its LDLR-degrading activity.	PCSK9 APOE	4.32e-05	2	229	2	18197702
Pubmed	Purification and assay of the human INO80 and SRCAP chromatin remodeling complexes.	SRCAP INO80	4.32e-05	2	229	2	17101442
Pubmed	Composition and Regulation of the Cellular Repertoire of SCF Ubiquitin Ligases.	FBXL12 FBXW8 BTRC FBXW11 FBXL15	5.65e-05	62	229	5	29103612
Pubmed	FBXO38 Ubiquitin Ligase Controls Centromere Integrity via ZXDA/B Stability.	FBXL12 BTRC FBXL15 PPP6C	5.70e-05	32	229	4	35813202
Pubmed	Global landscape of HIV-human protein complexes.	ATP5PF EPPK1 MARS1 SSBP1 ANAPC2 OSBPL6 BTRC FBXW11 GEMIN2 CNTNAP1 SPAG5 MRPS9	5.72e-05	457	229	12	22190034
Pubmed	Proximity interactions among centrosome components identify regulators of centriole duplication.	IQSEC1 FBXW11 SPAG5 SIPA1L1 CEP295 PCNT	5.74e-05	101	229	6	24613305
Pubmed	Control of chromosome stability by the beta-TrCP-REST-Mad2 axis.	FBXW8 BTRC FBXW11	5.93e-05	12	229	3	18354482
Pubmed	Characterization of the Cullin7 E3 ubiquitin ligase--heterodimerization of cullin substrate receptors as a novel mechanism to regulate cullin E3 ligase activity.	CUL7 FBXW8 BTRC	5.93e-05	12	229	3	21946088
Pubmed	SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.	EPPK1 MARS1 SPTAN1 RPS7 SRPRA RPS20 NUP205 PRDX3 HSP90AB1 DHX30 PDCD11 COASY	6.48e-05	463	229	12	34901782
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	CUL7 TULP4 MYO18B RGL2 MOS CCR10 CNTNAP1 KIFC2 MAP4K5 SMARCD2	7.23e-05	329	229	10	17474147
Pubmed	TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance.	FBXW8 BTRC FBXW11	7.67e-05	13	229	3	33962073
Pubmed	Human transcription factor protein interaction networks.	MARS1 SPTAN1 PSMD3 SSBP1 CUL7 SRCAP EMSY NUP205 HOXA10 HOXB9 BSG PRDX3 SYNE2 KIFC1 TEAD2 SMCHD1 INO80 DHX30 PPP6C CTCF MRPS9 PDCD11 SMARCD2	7.83e-05	1429	229	23	35140242
Pubmed	Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation.	MARS1 SRPRA NUP205 BSG ALDH18A1 PDZD8 HSP90AB1 ATAD2 DHRS7	8.04e-05	269	229	9	30442662
Interaction	PHTF2 interactions	OSBPL6 BTRC FBXW11 SPPL3 WDFY3	1.59e-06	19	222	5	int:PHTF2
GeneFamily	ATP binding cassette subfamily B	TAP2 ABCB5 ABCB8	1.11e-04	11	162	3	806
GeneFamily	WD repeat domain containing\|F-box and WD repeat domain containing	FBXW8 BTRC FBXW11	1.11e-04	11	162	3	559
GeneFamily	WD repeat domain containing	IFT172 WDR81 FBXW8 TULP4 BTRC WDR62 FBXW11 WDR97 WDFY3 CFAP44	1.29e-04	262	162	10	362
GeneFamily	PDZ domain containing	CNKSR1 STXBP4 PTPN3 PDZD8 LNX1 WHRN SIPA1L1	4.44e-04	152	162	7	1220
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	SPEG LRRC32 LRRTM3 IRAG1 PXDN NHS CACNA1H FRY HES4	6.76e-07	191	229	9	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHST14 LRRTM3 IRAG1 KCNJ8 CHST2 SETMAR MYOM3 AVIL	8.28e-07	144	229	8	121853910eeea1ea0642b3cc99f9200015480368
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPEG LRRTM3 MYO18B MYOM3 PPP1R3A UNC45B STAG3 PCNT	8.28e-07	144	229	8	f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PDGFA SPEG IRAG1 HOXA10 DUSP26 CACNA1H COL13A1 REM1 HES4	8.75e-07	197	229	9	b67ffd27d386c8186ef71ecdac96a462504507f0
ToppCell	Tracheal-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PDGFA LRRTM3 IRAG1 KCNJ8 CACNA1H CCR10 REM1 APOE HES4	9.52e-07	199	229	9	cefc3b50f65e95da850e4720c7b44bf584073491
ToppCell	Tracheal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PDGFA LRRTM3 IRAG1 KCNJ8 CACNA1H CCR10 REM1 APOE HES4	9.52e-07	199	229	9	aaa460c389cd6d38a13ba1a446f91a94f9573ad8
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CFTR HSPA12B TCF24 PTPN3 CNTNAP5 ANAPC2 ARL4D PKIA	1.37e-06	154	229	8	ce4b1e878cd88065fbfd2df18caf19703fec37d8
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SPEG IRAG1 ABCG4 OSBPL6 CACNA1H ENPP7 FRY HES4	2.10e-06	163	229	8	51dee6c21cbeca4e17d1cc386e203f0c403089e8
ToppCell	Pericytes-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	SNPH SPEG IRAG1 DUSP26 CACNA1H COL13A1 REM1 ARL4D	4.96e-06	183	229	8	d04deef7cd4e1738227a6593b84874ce0168c773
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRC32 LRRTM3 IRAG1 ADCY6 NHS CACNA1H FRY HES4	6.53e-06	190	229	8	d6b3a92119b210974a32af3fe9875d60eb02761e
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFTR BSG GMPR CHST2 APOE DLL1 ARL4D DHRS7	6.79e-06	191	229	8	feec8617678b778475747ad406c80231e07fd6f7
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SPEG IRAG1 DUSP26 SYNE2 CACNA1H FRY UNC45B HES4	7.33e-06	193	229	8	5260ac95a15cc43a19909badad0c7e3854da920d
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SPEG IRAG1 DUSP26 SYNE2 CACNA1H FRY UNC45B HES4	7.33e-06	193	229	8	5ec917931b438dd0e7fb03eb6af459d3ef6b84ba
ToppCell	PBMC-Mild\|PBMC / Compartment, Disease Groups and Clusters	SLC30A1 ERAP2 IQSEC1 GMPR TAP2 SMCHD1 SIPA1L1 HES4	7.61e-06	194	229	8	d1366b169d14011194e61d16b6b0953349febc78
ToppCell	(4)_Endothelial_cells-(42)_EC-sinusoidal\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	LRRC32 KCNJ8 GMPR CHST2 UBD APOE UNC45B MAP4K5	7.61e-06	194	229	8	4428b472c2042f88eae028b1770767512a515b75
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	MGAT4A HSPA12B ELMO1 SYNE2 LNX1 PITPNM2 ANO2 CRACDL	7.90e-06	195	229	8	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFTR CNTNAP5 BSG GMPR APOE DLL1 ARL4D DHRS7	7.90e-06	195	229	8	f7d9adadd37209ce1a38e5d621607b9c9270fed8
ToppCell	droplet-Bladder-nan-24m-Endothelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG LRRC32 IRAG1 HOXB9 KCNJ8 CACNA1H PPP1R3A UNC45B	8.20e-06	196	229	8	9a90dd26e7a43e3fd55e7c5d8354cfa4cdd5a6cc
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SPEG IRAG1 DUSP26 SYNE2 CACNA1H FRY UNC45B HES4	8.20e-06	196	229	8	1d94cecd378a829dd8014fc086d7fca48c953a91
ToppCell	droplet-Bladder-nan-24m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG LRRC32 IRAG1 HOXB9 KCNJ8 CACNA1H PPP1R3A UNC45B	8.20e-06	196	229	8	04dfef1bd4ebb0e9469ae80024dc177e469a2560
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SPEG IRAG1 DUSP26 SYNE2 CACNA1H FRY UNC45B HES4	8.20e-06	196	229	8	aacec48285bcb7ccf1b538187071885e3602cc49
ToppCell	droplet-Bladder-nan-24m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG LRRC32 IRAG1 HOXB9 KCNJ8 CACNA1H PPP1R3A UNC45B	8.51e-06	197	229	8	488e85991c5e668afb7672942726d9295b8fc7d8
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SETX SPTAN1 HSPA12B SYNE2 RGL2 PITPNM2 SMCHD1 FRY	9.50e-06	200	229	8	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	STX2 NAIP KIFC3 RGL2 SETMAR COL13A1	1.23e-05	99	229	6	a815a887094204de30b299e8907e81ad9a39c016
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPTAN1 LRRC32 TULP4 SYNE2 CCR10 SMCHD1 PKIA	2.37e-05	165	229	7	dbe231d00843cae917efd1abea6079ace3b45cdf
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SPTAN1 LRRC32 TULP4 SYNE2 CCR10 SMCHD1 PKIA	2.37e-05	165	229	7	9ccce713d4122054bf4bef4a7126d90cf9141b84
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|368C / Donor, Lineage, Cell class and subclass (all cells)	HOXA10 GMPR DLL1 KIFC2 CRACDL GAB3 OXNAD1	2.77e-05	169	229	7	0d96c0b4fd26fbc0bf44ff7bed2936eebcc55b74
ToppCell	10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	HOXA10 CYP26C1 GMPR MYO18B DLL1 FRY CRACDL	2.87e-05	170	229	7	97df5ffb328196c46568975d2d97722bcc753bf5
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPEG IRAG1 KCNJ8 MYO18B CACNA1E PPP1R3A MYBPC3	2.98e-05	171	229	7	09e653973962fb884878089d281f0947f7a285f6
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPEG IRAG1 KCNJ8 MYO18B CACNA1E PPP1R3A MYBPC3	2.98e-05	171	229	7	82de2885c8ce4fb7776da6a0207b3355c0910121
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	ERBB2 EVPL ADCY6 PXDN SEMA3B CACNA1H TMPRSS6	3.10e-05	172	229	7	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIFC1 COL13A1 ATAD2 SPAG5 LRR1 ARHGEF39 GYG1	3.10e-05	172	229	7	c06ca5d075937747952ed915c9db39a9f62072f9
ToppCell	10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	RPS7 CNTNAP5 PDZD8 ARMC8 HSP90AB1 CRPPA ALS2	3.10e-05	172	229	7	7fb43b3938b9a3b6935ec22d9d853e7d47b82b3c
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EVPL GMPR TRIM46 WHRN CRPPA VSTM2B ABCA6	3.21e-05	173	229	7	2b448acd5e584f24567204c31b8d74715e92f32a
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EVPL GMPR TRIM46 WHRN CRPPA VSTM2B ABCA6	3.21e-05	173	229	7	5086edc29c5a6137ca09877929a1317f9739c801
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRC32 LRRTM3 IRAG1 ADCY6 NHS FRY HES4	3.33e-05	174	229	7	015d3742d3d79a57413a333f00ef2d380a9848dd
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS7 RPS20 NEU2 HSP90AB1 TMPRSS6 APOE ARL4D	3.72e-05	177	229	7	ea2c2d2d7ffd34780882299229ff8614fdd7c79c
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS7 RPS20 NEU2 HSP90AB1 TMPRSS6 APOE ARL4D	3.72e-05	177	229	7	63b5ebbe505f22091bc7b0db818e01fae5d92bb7
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	EPPK1 PDGFA SPEG IRAG1 NHS CACNA1H HES4	3.99e-05	179	229	7	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	Bronchial_Biopsy-Mesenchymal-Smooth_muscle\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	LRRC32 IRAG1 LSMEM2 DUSP26 KCNJ8 CACNA1H APOE	4.14e-05	180	229	7	7085a851807e6a833965e1366946db0bbc5174e2
ToppCell	18-Airway-Epithelial-Submucosal_gland_basal\|Airway / Age, Tissue, Lineage and Cell class	CNKSR1 PDGFA LAMA1 HEPACAM APOE PKIA RNF39	4.28e-05	181	229	7	33938e6521712058312879f84f4ae381c2bfc379
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRRTM3 MYO18B MYOM3 PPP1R3A FRY UNC45B MYBPC3	4.28e-05	181	229	7	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP26 PRDX3 GMPR WHRN TOGARAM2 FITM1 MYBPC3	4.44e-05	182	229	7	c4a7007c864a9455a7e7447e28ccd380878a6a0f
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP26 PRDX3 GMPR WHRN TOGARAM2 FITM1 MYBPC3	4.44e-05	182	229	7	c315d820ffad912c014ba5eac6f5fa6de1a94384
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|tumor_Lung / Location, Cell class and cell subclass	LRRC32 IRAG1 KCNJ8 SGCE CACNA1H REM1 CNTNAP1	4.59e-05	183	229	7	a03dd563af9b15cb1f5de5732a229405a9f82d84
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS7 RPS20 NEU2 HSP90AB1 TMPRSS6 APOE ARL4D	4.59e-05	183	229	7	7534587fa35837c0aaca93c542f2eee493eba637
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	HOXD8 PCSK9 ANO2 TMPRSS6 MYBPC3	4.79e-05	77	229	5	10969743351c49a1d6d8ae1ef93098e7786ca3fe
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRRTM3 MYO18B MYOM3 PPP1R3A FRY UNC45B MYBPC3	4.92e-05	185	229	7	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	Immune-enucleated_erythrocyte\|World / Lineage, Cell type, age group and donor	BSG GMPR CHST2 MYO18B ABCB5 ATG14 TRAK2	5.09e-05	186	229	7	f9d5ec5cc8fd6e63bf25abe390307ec8a4a2d5a3
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR RPS20 SYNE2 TMPRSS6 ATAD2 PAXBP1 CEP295	5.09e-05	186	229	7	15ab6666748a641226e42e6ca6eeaf186a501c95
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFTR BSG CYP26C1 CHST2 DLL1 ARL4D DHRS7	5.09e-05	186	229	7	c2b65b8345487710704c3eb043e9bef2e2b1ff27
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR RPS20 SYNE2 TMPRSS6 ATAD2 PAXBP1 CEP295	5.09e-05	186	229	7	4ed1b97e2552f3c4134f25665d7513498ffac16c
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPTAN1 LRRC32 TULP4 SYNE2 CCR10 SMCHD1 PKIA	5.44e-05	188	229	7	9db3d3010cb8a1f3ee1cdccaf3cbaac3cf983fc5
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	SPTAN1 LRRC32 TULP4 SYNE2 CCR10 SMCHD1 PKIA	5.44e-05	188	229	7	72be6fe654f3a5f654d3b9680145bce7ae9b721d
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFA HEPACAM DUSP26 OPALIN APLP1 APOE TMEM9B	5.44e-05	188	229	7	87fd5e2dd01583baf7e018bff8750d20a557a20f
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SPEG IRAG1 DUSP26 COL13A1 FRY UNC45B HES4	5.63e-05	189	229	7	07208d32afca6f93207a2ac35b647b31a9f71b7c
ToppCell	facs-Heart-RA-24m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 LRRTM3 REM1 TMPRSS6 APOE PPP1R3A CDH22	5.63e-05	189	229	7	e4efbb0733b382f4c855f6653dcddf36e0f8df28
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SPEG IRAG1 DUSP26 COL13A1 FRY UNC45B HES4	5.63e-05	189	229	7	032f169e8ede653117919bf97c17f92043320b3c
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC30A1 ELMO1 PXDN CHST2 PITPNM2 PCDHAC1 FRY	5.63e-05	189	229	7	09dd2b3d89416192e84abe302a6237b8f3fdcb6e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPTAN1 LRRC32 SYNE2 CCR10 CNTNAP1 PKIA	5.74e-05	130	229	6	d47d4ff1263815896470d854d25306eb36919e70
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SPTAN1 LRRC32 SYNE2 CCR10 CNTNAP1 PKIA	5.74e-05	130	229	6	ad57b210c96caedadc1027b4d7a56b1bc389b137
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HEPACAM DUSP26 OPALIN SGCE APLP1 APOE TMEM9B	5.82e-05	190	229	7	19faabab3f27579e380d2ac625876c6439933b44
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP5 BSG GMPR APOE DLL1 GYG1 DHRS7	5.82e-05	190	229	7	bb3b396d78887d5d6f93a05c8ed4d703591bf33f
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFA IRAG1 ADCY6 KCNJ8 CACNA1H MYO18B REM1	5.82e-05	190	229	7	1ab3f19f1ce9f58e5125135704d94655a2e330a0
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDGFA LRRC32 LSMEM2 CCR10 REM1 FRY HES4	6.02e-05	191	229	7	239c1e68eb1cbe3e137a99fbd6eeb8d64c919ffd
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFA SPEG IRAG1 ADCY6 KCNJ8 REM1 MYOM3	6.02e-05	191	229	7	ff7874cc005760a8f3b2e8072fbe418b6bfacaa8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPEG IRAG1 MYO18B COL13A1 FRY UNC45B HES4	6.22e-05	192	229	7	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPEG IRAG1 MYO18B COL13A1 FRY UNC45B HES4	6.22e-05	192	229	7	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFA SPEG IRAG1 KCNJ8 CACNA1H REM1 OXNAD1	6.42e-05	193	229	7	b9e11cd0896c0868aab7faec4ab7ab4d4e4d1b47
ToppCell	wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	BSG MTMR3 IQSEC1 GMPR ARHGEF37 TRAK2 PCNT	6.42e-05	193	229	7	be75abfdf5301cf33df8ee9ed92504d44fdf19a6
ToppCell	LA\|World / Chamber and Cluster_Paper	IRAG1 PCNX2 XYLT1 PXDN CACNA1E ABCA6 SCARA5	6.42e-05	193	229	7	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	18-Airway-Mesenchymal-Pericyte\|Airway / Age, Tissue, Lineage and Cell class	PDGFA LRRC32 LSMEM2 KCNJ8 REM1 APOE HES4	6.42e-05	193	229	7	9f4ba9c29ab8071d57e4187085ec3a47ab61e968
ToppCell	(4)_Endothelial_cells-(42)_EC-sinusoidal\|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	RPS20 KCNJ8 GMPR CHST2 UBD APOE MAP4K5	6.64e-05	194	229	7	4199900d16623eca02d674d5ada7f0989e47955e
ToppCell	15-Airway-Mesenchymal-Pericyte\|Airway / Age, Tissue, Lineage and Cell class	PDGFA LRRC32 IRAG1 LSMEM2 APOE UNC45B HES4	6.64e-05	194	229	7	5c1218d239c88082496924653ed2a092dc44a906
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG IRAG1 KCNJ8 CACNA1H REM1 PPP1R3A OXNAD1	6.64e-05	194	229	7	fb234d97191c95b7880280c6e4ed5df124ffb0e1
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFA SPEG IRAG1 KCNJ8 CACNA1H REM1 OXNAD1	6.64e-05	194	229	7	b8a130ffae68ffe550bf335460a1ec1035cf8d8d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFTR BSG GMPR APOE DLL1 ARL4D DHRS7	6.64e-05	194	229	7	6165c00ec06a8393f23b0c62f679c143839b03b1
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	LRRC32 MGAT4A ELMO1 SYNE2 LNX1 ANO2 CRACDL	6.85e-05	195	229	7	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MGAT4A CXCR5 MYO18B WHRN GYG1 CRACDL OXNAD1	6.85e-05	195	229	7	69201b1172bcf0999c726516e4d30863afceab0b
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HMGCR TULP4 GMPR PCSK9 TMPRSS6 APLP1 REV3L	6.85e-05	195	229	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Fibroblasts-Pericytes\|Fibroblasts / lung cells shred on cell class, cell subclass, sample id	PDGFA SPEG LRRC32 IRAG1 SYNE2 CACNA1H FRY	6.85e-05	195	229	7	c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	SPEG IRAG1 DUSP26 CACNA1H FRY UNC45B HES4	7.08e-05	196	229	7	541b1fcf509e362f6f48720046cb5378aaf7c591
ToppCell	COVID-19-Heart-Mito_CM\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DUSP26 MYO18B MYOM3 UNC45B PKIA FITM1 MYBPC3	7.31e-05	197	229	7	44e49943d62bfe622b40ad0460093d31540544df
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	LRRC32 ELMO1 SYNE2 LNX1 PITPNM2 ANO2 CRACDL	7.31e-05	197	229	7	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PDGFA SPEG IRAG1 HOXA10 ABCG4 DUSP26 CACNA1H	7.31e-05	197	229	7	d1cb30ec4f3024541e9876c70bf63fe4d5c55bf1
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_3\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	SRCAP TKTL2 XYLT1 ZNF474 FITM1 RNF39	7.38e-05	136	229	6	5e209185b5f6e9347829fc9066f0b2c3711df057
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	PDGFA LRRC32 KCNJ8 SYNE2 CHST2 REM1 HES4	7.54e-05	198	229	7	86a4c8e859ce11a95875f8844963baeb1ba898ec
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Transitional_AT2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	CFTR CNTNAP5 PXDN CYP26C1 TEAD2 CDH22 GYG1	7.78e-05	199	229	7	cd581d7330b471431ef427f8a4f5be553f70e068
ToppCell	Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	PDGFA SPEG IRAG1 DUSP26 CACNA1H UNC45B HES4	7.78e-05	199	229	7	c8bc05dece8b8a87d4a7a3e8112b924e15217de1
ToppCell	distal-2-mesenchymal-Airway_Smooth_Muscle\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PDGFA SPEG IRAG1 SGCE CACNA1H REM1 UNC45B	7.78e-05	199	229	7	af226a6c50747dad9ca696463e715913b3ac17c0
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PDGFA SPEG IRAG1 DUSP26 CACNA1H FRY HES4	7.78e-05	199	229	7	c2903b1a4b91e94bbdaa909bacefe901255cf248
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SYNE2 WDR62 KIFC1 TTF2 ATAD2 SPAG5 ARHGEF39	7.78e-05	199	229	7	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDGFA SPEG IRAG1 DUSP26 CACNA1H UNC45B HES4	7.78e-05	199	229	7	78b245d40c1e169ff2d26907b63d732e34529c5f
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PDGFA SPEG IRAG1 DUSP26 CACNA1H UNC45B HES4	7.78e-05	199	229	7	8e1e95c3a4b856415af208be6ad977e575bac189
ToppCell	11.5-Distal-Mesenchymal-Mesenchyme_RSPO2+\|Distal / Age, Tissue, Lineage and Cell class	RPS7 RPS20 CHST2 COL13A1 APOE ABCA6 GYG1	7.78e-05	199	229	7	cea1b30f3e3a9b4ccbc8b57f82352067be1a1d68
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW10\|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type.	SYNE2 WDR62 PCSK9 TEAD2 ATAD2 SPAG5 ARL4D	7.78e-05	199	229	7	8e72efcd421639ac36ed036ee13f13de070d361f
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SYNE2 WDR62 KIFC1 TTF2 ATAD2 SPAG5 ARHGEF39	7.78e-05	199	229	7	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFA SCNM1 NHS APOE KPTN STAG3	8.00e-05	138	229	6	c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SETX SPTAN1 HSPA12B RGL2 PITPNM2 SMCHD1 FRY	8.03e-05	200	229	7	bcd1cc96197929d6011903803b6f4ccdcf52b4ce
ToppCell	Transverse-(3)_ILC-(30)_ILC\|Transverse / shred on region, Cell_type, and subtype	HOXA10 HSP90AB1 ABCB5 VSTM2B DLL1 FRY CRACDL	8.03e-05	200	229	7	528520dc98775aca6cc7568fedf5906ea55e0bea
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	RPS7 CBLC HMGCR SYNE2 PLCB3 PCSK9 PITPNM2 CRPPA APOE ABCA6 MAP4K5	5.46e-06	264	221	11	EFO_0008317, EFO_0020944
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	CBLC HMGCR SYNE2 PLCB3 PCSK9 PITPNM2 CRPPA APOE ABCA6 MAP4K5	7.43e-06	222	221	10	EFO_0008317, EFO_0020943
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	RPS7 CBLC HMGCR SYNE2 PLCB3 PCSK9 NPEPPS APOE ABCA6 MAP4K5 MYBPC3	1.36e-05	291	221	11	EFO_0008317, EFO_0020946
Disease	free cholesterol to total lipids in very small VLDL percentage	HMGCR PCSK9 APOE ABCA6 MAP4K5	1.72e-05	43	221	5	EFO_0022290
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	CBLC HMGCR SYNE2 PLCB3 PCSK9 APOE ABCA6 MAP4K5	1.84e-05	150	221	8	EFO_0004611, EFO_0020947
Disease	cholesterol to total lipids in large VLDL percentage	HMGCR PCSK9 APOE ABCA6 MAP4K5	2.16e-05	45	221	5	EFO_0022236
Disease	cholesteryl esters to total lipids in small VLDL percentage	HMGCR PCSK9 APOE ABCA6 MAP4K5	3.28e-05	49	221	5	EFO_0022256
Disease	level of Sterol ester (27:1/18:2) in blood serum	CBLC NKPD1 PCSK9 APOE	4.02e-05	26	221	4	OBA_2045194
Disease	triglycerides to total lipids in very large VLDL percentage	HMGCR PCSK9 APOE ABCA6 MAP4K5	4.82e-05	53	221	5	EFO_0022340
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	CBLC HMGCR PLCB3 PCSK9 NPEPPS CRPPA APOE ABCA6 MAP4K5	5.40e-05	225	221	9	EFO_0008317, EFO_0020947
Disease	cholesteryl esters to total lipids in large VLDL percentage	HMGCR PCSK9 APOE ABCA6 MAP4K5	6.31e-05	56	221	5	EFO_0022250
Disease	Malignant neoplasm of breast	ERBB2 PDGFA STXBP4 SPTAN1 RPS7 EMSY CXCR5 HOXB9 SYNE2 MTMR3 NHS DLEC1 ZNF541 UBD TMPRSS6 DLL1 PPP1R3A UNC45B SIPA1L1 ABCB8 DIP2C	6.36e-05	1074	221	21	C0006142
Disease	free cholesterol to total lipids in very large VLDL percentage	HMGCR PCSK9 APOE ABCA6 MAP4K5	8.11e-05	59	221	5	EFO_0022289
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	CBLC HMGCR SYNE2 PLCB3 PCSK9 APOE MAP4K5	1.11e-04	144	221	7	EFO_0004611, EFO_0020943
Disease	apolipoprotein B measurement	WDR81 CBLC SRPRA HMGCR SYNE2 CYP26C1 PPP1R37 NKPD1 PLCB3 PCSK9 NPEPPS FBXL15 APOE ABCA6 MAP4K5	1.57e-04	663	221	15	EFO_0004615
Disease	Sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0) measurement	SYNE2 APOE	1.67e-04	3	221	2	EFO_0022111
Disease	N-palmitoyl-sphinganine (d18:0/16:0) measurement	SYNE2 APOE	1.67e-04	3	221	2	EFO_0800428
Disease	remnant cholesterol measurement	CBLC HMGCR PCSK9 APOE ABCA6 MAP4K5	1.67e-04	108	221	6	EFO_0010815
Disease	triglycerides to total lipids in large VLDL percentage	HMGCR PCSK9 APOE ABCA6	2.05e-04	39	221	4	EFO_0022332
Disease	free cholesterol measurement	CBLC HMGCR PCSK9 APOE ABCA6 MAP4K5	2.14e-04	113	221	6	EFO_0008591
Disease	liver fat measurement, liver disease biomarker	TMPRSS6 APOE MAP4K5	2.16e-04	16	221	3	EFO_0006845, EFO_0010821
Disease	low density lipoprotein cholesterol measurement, lipid measurement	CBLC HMGCR PCSK9 APOE ABCA6 MAP4K5	2.24e-04	114	221	6	EFO_0004529, EFO_0004611
Disease	total cholesterol measurement, low density lipoprotein cholesterol measurement	CBLC HMGCR PCSK9 APOE ABCA6 MAP4K5	2.24e-04	114	221	6	EFO_0004574, EFO_0004611
Disease	cholesterol in very small VLDL measurement	HMGCR PCSK9 APOE ABCA6	2.27e-04	40	221	4	EFO_0022231
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	CBLC HMGCR PCSK9 APOE ABCA6 MAP4K5	2.96e-04	120	221	6	EFO_0004611, EFO_0004639
Disease	Hypercholesterolemia, Familial	HMGCR PCSK9 APOE	3.11e-04	18	221	3	C0020445
Disease	Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) measurement	SYNE2 APOE	3.32e-04	4	221	2	EFO_0022112
Disease	Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) measurement	SYNE2 APOE	3.32e-04	4	221	2	EFO_0022116
Disease	coronary artery disease (implicated_via_orthology)	KCNJ8 APOE	3.32e-04	4	221	2	DOID:3393 (implicated_via_orthology)
Disease	palmitoyl sphingomyelin (d18:1/16:0) measurement	PCSK9 APOE	3.32e-04	4	221	2	EFO_0800300
Disease	total lipids in very small VLDL measurement	HMGCR PCSK9 APOE ABCA6	3.59e-04	45	221	4	EFO_0022156
Disease	cholesteryl ester measurement, low density lipoprotein cholesterol measurement	CBLC HMGCR PCSK9 APOE ABCA6 MAP4K5	3.85e-04	126	221	6	EFO_0004611, EFO_0010351
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	CBLC SYNE2 PLCB3 PCSK9 ABCA6 MAP4K5	4.01e-04	127	221	6	EFO_0008595, EFO_0020947
Disease	esterified cholesterol measurement	CBLC HMGCR PCSK9 APOE ABCA6 MAP4K5	4.19e-04	128	221	6	EFO_0008589
Disease	free cholesterol in small VLDL measurement	HMGCR PCSK9 APOE ABCA6	4.24e-04	47	221	4	EFO_0022272
Disease	free cholesterol in very small VLDL measurement	HMGCR PCSK9 APOE ABCA6	4.24e-04	47	221	4	EFO_0022275
Disease	free cholesterol in medium VLDL measurement	HMGCR PCSK9 APOE ABCA6	4.24e-04	47	221	4	EFO_0022269
Disease	systemic scleroderma	ELMO1 CXCR5 PXDN TULP4 UNC45B	4.54e-04	85	221	5	EFO_0000717
Disease	total lipids in lipoprotein particles measurement	HMGCR PCSK9 APOE MAP4K5	4.60e-04	48	221	4	EFO_0022309
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	CBLC HMGCR PLCB3 PCSK9 APOE CDH22 ABCA6 MAP4K5 RNF39	4.98e-04	303	221	9	EFO_0004612, EFO_0020945
Disease	phospholipids in medium LDL measurement	HMGCR PCSK9 ABCA6 MAP4K5	4.98e-04	49	221	4	EFO_0022183
Disease	intermediate density lipoprotein measurement	CBLC HMGCR PCSK9 APOE ABCA6	5.05e-04	87	221	5	EFO_0008595
Disease	Sphingomyelin (d18:1/20:0, d16:1/22:0) measurement	SYNE2 APOE	5.50e-04	5	221	2	EFO_0022109
Disease	disintegrin and metalloproteinase domain-containing protein 11 measurement	RPS7 APOE	5.50e-04	5	221	2	EFO_0801529
Disease	Arterial Fatty Streak	BSG APOE	5.50e-04	5	221	2	C0015697
Disease	Atheroma	BSG APOE	5.50e-04	5	221	2	C0264956
Disease	Menkes disease (implicated_via_orthology)	BTRC FBXW11	5.50e-04	5	221	2	DOID:1838 (implicated_via_orthology)
Disease	Plaque, Atherosclerotic	BSG APOE	5.50e-04	5	221	2	C2936350
Disease	Fibroatheroma	BSG APOE	5.50e-04	5	221	2	C2936351
Disease	phospholipids in very small VLDL measurement	HMGCR PCSK9 APOE ABCA6	5.81e-04	51	221	4	EFO_0022300
Disease	cholesterol to total lipids in small VLDL percentage	HMGCR PCSK9 ABCA6 MAP4K5	5.81e-04	51	221	4	EFO_0022242
Disease	lipid measurement, lipoprotein measurement	HMGCR PCSK9 APOE ABCA6 MAP4K5	5.90e-04	90	221	5	EFO_0004529, EFO_0004732
Disease	Intellectual Disability	CNKSR1 LAMA1 RNASEH2C IQSEC1 MED23 WDR62 FBXW11 CACNA1E DLL1 FRY CTCF	5.95e-04	447	221	11	C3714756
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	CBLC HMGCR PCSK9 APOE ABCA6 MAP4K5	6.00e-04	137	221	6	EFO_0004611, EFO_0008591
Disease	phospholipids in medium VLDL measurement	HMGCR PCSK9 APOE ABCA6	6.26e-04	52	221	4	EFO_0022154
Disease	total lipids in LDL measurement	HMGCR PCSK9 ABCA6 MAP4K5	6.26e-04	52	221	4	EFO_0022308
Disease	phospholipids in large LDL measurement	HMGCR PCSK9 ABCA6 MAP4K5	6.73e-04	53	221	4	EFO_0022174
Disease	cholesterol in small VLDL measurement	HMGCR PCSK9 APOE ABCA6	6.73e-04	53	221	4	EFO_0022228
Disease	free cholesterol in small LDL measurement	CBLC HMGCR PCSK9 ABCA6	6.73e-04	53	221	4	EFO_0022271
Disease	cholesteryl esters to total lipids in very large VLDL percentage	PCSK9 APOE ABCA6 MAP4K5	6.73e-04	53	221	4	EFO_0022258
Disease	apolipoprotein A 1 measurement	RPS7 NUP205 XPO6 CYP26C1 PLCB3 DLEC1 MED23 PCSK9 PITPNM2 NPEPPS APOE ABCA6 CTCF MAP4K5 HES4 MYBPC3	7.06e-04	848	221	16	EFO_0004614
Disease	cholesteryl ester measurement, intermediate density lipoprotein measurement	CBLC HMGCR PCSK9 APOE ABCA6	7.20e-04	94	221	5	EFO_0008595, EFO_0010351
Disease	cholesterol to total lipids in very large VLDL percentage	PCSK9 APOE ABCA6 MAP4K5	7.22e-04	54	221	4	EFO_0022244
Disease	lipid measurement, intermediate density lipoprotein measurement	CBLC HMGCR PCSK9 APOE ABCA6	7.92e-04	96	221	5	EFO_0004529, EFO_0008595
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	CBLC SYNE2 PLCB3 PCSK9 APOE ABCA6 MAP4K5	8.11e-04	200	221	7	EFO_0004611, EFO_0020945
Disease	Congenital muscular dystrophy (disorder)	SYNE2 CRPPA	8.21e-04	6	221	2	C0699743
Disease	stearoyl sphingomyelin (d18:1/18:0) measurement	SYNE2 APOE	8.21e-04	6	221	2	EFO_0800611
Disease	interleukin-22 receptor subunit alpha-1 measurement	RPS7 APOE	8.21e-04	6	221	2	EFO_0020499
Disease	free cholesterol to total lipids in large HDL percentage	HMGCR PCSK9 ABCA6 MAP4K5	8.29e-04	56	221	4	EFO_0022279
Disease	Left ventricular mass to end-diastolic volume ratio	PXDN MYO18B SIPA1L1	8.44e-04	25	221	3	EFO_0010556
Disease	total lipids in large LDL	HMGCR PCSK9 ABCA6 MAP4K5	8.86e-04	57	221	4	EFO_0022163
Disease	cholesterol in large LDL measurement	HMGCR PCSK9 ABCA6 MAP4K5	8.86e-04	57	221	4	EFO_0021901
Disease	free cholesterol to total lipids in medium VLDL percentage	HMGCR PCSK9 ABCA6 MAP4K5	8.86e-04	57	221	4	EFO_0022284
Disease	total cholesterol measurement, intermediate density lipoprotein measurement	CBLC HMGCR PCSK9 APOE ABCA6	9.10e-04	99	221	5	EFO_0004574, EFO_0008595
Disease	phospholipid measurement, intermediate density lipoprotein measurement	CBLC HMGCR PCSK9 APOE ABCA6	9.10e-04	99	221	5	EFO_0004639, EFO_0008595
Disease	triglycerides to total lipids in small VLDL percentage	HMGCR PCSK9 ABCA6 MAP4K5	9.47e-04	58	221	4	EFO_0022338
Disease	phospholipids in LDL measurement	HMGCR PCSK9 ABCA6 MAP4K5	9.47e-04	58	221	4	EFO_0022294
Disease	level of Sterol ester (27:1/16:0) in blood serum	CBLC PCSK9 APOE	9.49e-04	26	221	3	OBA_2045191
Disease	cholesteryl esters to total lipids in large HDL percentage	CYP26C1 PLCB3 APOE MAP4K5	1.01e-03	59	221	4	EFO_0022248
Disease	phospholipids in small LDL measurement	HMGCR PCSK9 ABCA6 MAP4K5	1.01e-03	59	221	4	EFO_0022297
Disease	cholesterol to total lipids in small LDL percentage	HMGCR PCSK9 APOE	1.06e-03	27	221	3	EFO_0022241
Disease	cholesterol to total lipids in medium LDL percentage	HMGCR PCSK9 APOE	1.06e-03	27	221	3	EFO_0022238
Disease	phospholipids in small VLDL measurement	HMGCR PCSK9 APOE ABCA6	1.08e-03	60	221	4	EFO_0022146
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	CBLC SYNE2 PLCB3 PCSK9 MAP4K5	1.09e-03	103	221	5	EFO_0008595, EFO_0020944
Disease	free cholesterol measurement, intermediate density lipoprotein measurement	CBLC HMGCR PCSK9 APOE ABCA6	1.14e-03	104	221	5	EFO_0008591, EFO_0008595
Disease	epididymis-specific alpha-mannosidase measurement	MAN2B2 APOE	1.14e-03	7	221	2	EFO_0801577
Disease	lethal congenital contracture syndrome (is_implicated_in)	ADCY6 CNTNAP1	1.14e-03	7	221	2	DOID:0060558 (is_implicated_in)
Disease	LDL cholesterol change measurement	PCSK9 APOE	1.14e-03	7	221	2	EFO_0007804
Disease	glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement	SYNE2 PCSK9	1.14e-03	7	221	2	EFO_0800551
Disease	palmitoyl dihydrosphingomyelin (d18:0/16:0) measurement	SYNE2 PCSK9	1.14e-03	7	221	2	EFO_0800400
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	PHF20 HMGCR PLCB3 PCSK9 APOE ABCA6 MAP4K5	1.23e-03	215	221	7	EFO_0008317, EFO_0008591
Disease	familial hyperlipidemia	CBLC HMGCR PCSK9 APOE MAP4K5	1.24e-03	106	221	5	MONDO_0001336
Disease	triglycerides to total lipids in medium VLDL percentage	HMGCR PCSK9 ABCA6 MAP4K5	1.29e-03	63	221	4	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	HMGCR PCSK9 ABCA6 MAP4K5	1.29e-03	63	221	4	EFO_0022239
Disease	Congenital Hydrocephalus	WDR81 CRPPA	1.52e-03	8	221	2	C0020256
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP5 CNTNAP1	1.52e-03	8	221	2	DOID:0060308 (implicated_via_orthology)
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	CBLC HMGCR PLCB3 PCSK9 APOE ABCA6 MAP4K5	1.56e-03	224	221	7	EFO_0004574, EFO_0008317
Disease	lipoprotein A measurement	PSMD3 TULP4 PCSK9 APOE ABCA6	1.58e-03	112	221	5	EFO_0006925
Disease	L-Selectin measurement	PSMD3 EVPL MAP4K5	1.60e-03	31	221	3	EFO_0008202
Disease	phospholipids:total lipids ratio	HMGCR PCSK9 FBXL15 APOE ABCA6 MAP4K5 MYBPC3	1.68e-03	227	221	7	EFO_0020946

Protein segments in the cluster

Peptide	Gene	Start	Entry
HLSRTCLLIAVRTNR	NAIP	571	Q13075
TVLQFLTRLRRHASL	CBARP	286	Q8N350
LESILRRRFTHQSDV	ERBB2	891	P04626
TFLSILRDTVLTHLR	ABCG4	381	Q9H172
LSTRRVASLLSQDIH	AVIL	46	O75366
LVLATHLAARRAARS	CCR10	61	P46092
RVNIADLAVRRHSRI	CNTNAP1	331	P78357
NSERLLVDTRRFLIH	nan	266	Q9N2K0
LRSIILTHVIRAQRA	ELMO1	271	Q92556
QSTEELRVRLASHLR	APOE	146	P02649
RLAVRELAAATLTHV	ARL4D	151	P49703
VLHRLSLLERVSAEA	ANAPC2	246	Q9UJX6
ERRNSILTETLHRFS	CFTR	656	P13569
LVLVILERHRQTRSS	CXCR5	71	P32302
RAFRTVTLLRNHLNT	CTCF	301	P49711
TAQLLREVAHSRRAA	CBLC	51	Q9ULV8
NTHVDLRTLRAVRVL	CACNA1E	181	Q15878
AAVLRSAAARLRQIH	BCL2L10	46	Q9HD36
ANLRRSHILELTSVI	ATG14	191	Q6ZNE5
IAVALTTSRRQHRDS	ALS2	1321	Q96Q42
LSRSIVRSRAHSTAV	ADCY6	731	O43306
RASEDRSLLHQRLAV	ARHGEF37	21	A1IGU5
LRERLARINTHTLSK	ARHGEF37	231	A1IGU5
HRLSTIRSADLIVTL	ABCB5	581	Q2M3G0
TLRRAIHRIAALSLV	BHLHA9	106	Q7RTU4
ITLRRVLVGHRAAVN	BTRC	416	Q9Y297
LLRERRADHVILFST	ABCA6	656	Q8N139
HATRVIALINDQRRA	APLP1	376	P51693
RSLRARNIVQSTEHL	ATAD2	131	Q6PL18
ATRSRIVHEILKRTA	ANO2	276	Q9NQ90
AAERQRIAHTRALSV	C1orf147	161	Q96MC9
LLHKSTINREATRLR	DHX30	1056	Q7L2E3
SLVLSARRVHELERV	DHRS7	76	Q9Y394
TLVFSNHALRRLQER	CFAP44	1641	Q96MT7
HSDLSRLTELSLRRR	ASTE1	426	Q2TB18
TRAARLISETAQRVH	ARHGEF39	181	Q8N4T4
SARQVEHVLSLLRGR	ANTKMT	61	Q9BQD7
VALLFTLIHRRRSSI	OPALIN	46	Q96PE5
IRRISSLERAAEHAQ	DRD5	256	P21918
VIIQSALRAHLARAR	IQCE	606	Q6IPM2
ASRESHSRELALVIR	PTPN3	581	P26045
RISLVEAGVTRHRSI	CRPPA	116	A4D126
QVVHQRRSATSSLRR	INO80	986	Q9ULG1
RTGRRNAIHDILVSS	PKIA	16	P61925
SIELRVTSLNRQRSH	NUP205	1121	Q92621
ATHIALRTVRRFLEI	GDAP2	181	Q9NXN4
ERLRIAEHRISQRSS	MGAT4A	46	Q9UM21
IHEDSTNRRRLSELL	HSP90AB1	441	P08238
TLHLRSNSLRTIPVR	LRRTM2	161	O43300
LHQRLSLRQAVITVR	DUSP13	146	Q6B8I1
RRAETLIFSRHAVIA	KCNJ8	186	Q15842
HSLIRQLARRCSEVR	GEMIN2	231	O14893
RRIEVSHALALTERQ	HOXD8	226	P13378
ITSAVLVERLGRRHL	SLC2A7	336	Q6PXP3
LTLLESSARTILHNR	LRR1	321	Q96L50
TLSSAAQTHQLRRLR	GMIP	486	Q9P107
RNLSIIREHASLTRT	GAB3	456	Q8WWW8
ETHERGVSIRRQLLS	HMGCR	486	P04035
RLVTRHAARTIQTAF	IQSEC1	131	Q6DN90
LLHLARQNRAVARTA	KIFC1	516	Q9BW19
VRSIASHVRPDRQTL	DDX42	421	Q86XP3
AVLHRLAARLSSRAE	IRAG1	596	Q9Y6F6
RVRIHDLRSGNIALS	FBXW8	456	Q8N3Y1
HLSVRERAEALIRSS	PCNX2	2006	A6NKB5
THLSQSERTARRLQA	PCSK9	86	Q8NBP7
SLIQASELVLTRLRH	KPTN	396	Q9Y664
SELVLTRLRHQVEQR	KPTN	401	Q9Y664
TVLSIASHQERLRAL	OR51G1	226	Q8NGK1
RHIINTSSRLLNLRQ	PDZD8	936	Q8NEN9
AEDRRSLLHLSSRLN	CUL7	1001	Q14999
HSRAATQELALLISR	EVPL	31	Q92817
TDITLRRVLVGHRAA	FBXW11	351	Q9UKB1
LERIGARALVAHVRT	MED23	811	Q9ULK4
ASERRVHLVVSRQVR	LNX1	451	Q8TBB1
RLTTVRRLLSEKATH	ANKRD49	86	Q8WVL7
LTRERRLEISRSVHL	HOXA10	361	P31260
RLEISRSVHLTDRQV	HOXA10	366	P31260
LLVFSRSSRRRLHSL	NPEPPSL1	26	A6NEC2
HLQSRVDSTRAIERL	PAXBP1	416	Q9Y5B6
TLIHTISLRRLSFCR	OR5J2	156	Q8NH18
FLRSRNHLLRTISAQ	PITPNM2	1286	Q9BZ72
EQLRRSRHSRTFLVE	HSPA12B	286	Q96MM6
ELRSRLNRIHSESII	OSBPL6	436	Q9BZF3
EIRHQIGNTLIRRLS	PHACTR4	576	Q8IZ21
ALSRLLADQERRHSQ	PCNT	1801	O95613
LRHERLLTEQLSQRT	PCNT	2761	O95613
REATRRETHILRQVA	PHKG2	71	P15735
RARRARLQHSSALTA	CRACDL	306	Q6NV74
RLRHEILLSQSVRQA	ALDH18A1	126	P54886
VAARLSVSLLRHTQL	IFT172	1556	Q9UG01
HLIRTRSTASRDERN	PPP1R3A	326	Q16821
VARALRIRSSLAVLH	PPP1R37	211	O75864
RIRSSLAVLHLENAS	PPP1R37	216	O75864
TRDRRHEVARLLNLS	HOXB9	211	P17482
IEAASLRLTLSTLRH	OXNAD1	21	Q96HP4
LDREQRATHLLVLTA	PCDHAC1	191	Q9H158
LAENSLTRLTRHTFR	LRRC32	156	Q14392
VVTLNARSHLRARVQ	NEU2	231	Q9Y3R4
LTRIRNNSAIHIRVF	POP7	121	O75817
RRHITESVNSIRRLE	PLCB3	1126	Q01970
SVIRSAVSVHLRRNI	ATP5PF	11	P18859
RLAAVRCLHSLSRSV	ARMC8	401	Q8IUR7
RCLHSLSRSVQQLRT	ARMC8	406	Q8IUR7
LKQHRTTRRLVVLAT	GYG1	26	P46976
QHRALRRQVTSLVVL	SLC2A11	266	Q9BYW1
VFLATRRVAVTARHL	FITM1	111	A5D6W6
RRVAVTARHLSRLVV	FITM1	116	A5D6W6
ERLISRLATQRHLTV	DLL1	141	O00548
SAAGHLDVVRSLLRR	FEM1A	91	Q9BSK4
QELRREFTVSLHLAR	IL27	41	Q8NEV9
QAIITLRVRSHLAAL	BSG	311	P35613
VAHRDQRDINLSSLR	DIP2C	601	Q9Y2E4
RILATSDIAVRLLHT	DNAI7	241	Q6TDU7
FLITRRRHDSAQLVL	ADAM9	291	Q13443
NVRTILLGEHRLVRS	CYP26C1	101	Q6V0L0
RLSQVSLLERSSTHI	C17orf80	501	Q9BSJ5
TRAHPNRSVAVTLRL	IDUA	446	P35475
RHLRSLRRVQVTAAL	HES4	86	Q9HCC6
TRVRFINLARTLQAH	MARCHF7	666	Q9H992
TTALRQRSALALQHR	MAN2B2	831	Q9Y2E5
VLQSESLRILAHTLR	LSMEM2	121	Q8N112
SIKIRRESRHIALSN	ERAP2	221	Q6P179
ASRTLRTAGVHIIRE	HEPACAM	391	Q14CZ8
ALRLSQLRTVLVADH	DALRD3	131	Q5D0E6
NHAQLSRASLRIRIL	CDH22	476	Q9UJ99
LSISTERHRAEVRRA	EMSY	56	Q7Z589
RFSNVIRAHTRLESR	FRY	1561	Q5TBA9
AHFRTAELQARVLRL	COL13A1	61	Q5TAT6
ELSRRATFIRVTQQH	GMPR	326	P36959
LRESIARNHLTDRLN	ENPP7	226	Q6UWV6
ATTARIRDTLRRVLN	EIF4E2	191	O60573
HNVSLSAIRTVRVLR	CACNA1H	191	O95180
ETLSRALSHDRQLIS	CEP295	731	Q9C0D2
RLRPSSLRTQDISHL	DLEC1	81	Q9Y238
LLTQTRLITQSALHR	SCNM1	106	Q9BWG6
HRTRLQDLRVLVSNA	SCARA5	241	Q6ZMJ2
VLVDRAIHSRLSRQS	PEX1	786	O43933
AIHSRLSRQSISTRE	PEX1	791	O43933
LLVFSRSSRRRLHSL	NPEPPS	26	P55786
RSSRSHALVTLTLRA	KIFC2	596	Q96AC6
HSVSINARRNRITLT	CNTNAP5	451	Q8WYK1
RISRTAITTASIRRH	FAM126B	311	Q8IXS8
IIRHTIRSTNRNARA	MAP4K5	316	Q9Y4K4
NIHSIRRSFQSLRLL	MTMR3	351	Q13615
SASELRIQLRRTHQA	REM1	171	O75628
RRSSRLSTNGTHEIL	PHF20	326	Q9BVI0
RLRHDNIVRVVAAST	MOS	111	P00540
RASAGRTVLVIAHRL	ABCB8	656	Q9NUT2
AIHRIRITLTSRNVK	RPS20	16	P60866
TLEALVRHLLDTRTS	RGL2	96	O15211
QSVISHLLRVRARVA	SNX4	231	O95219
ERLARLSAQIQEHRS	TRIM46	341	Q7Z4K8
RPRSRTLTAVHDAIL	RPS7	116	P62081
ISLREEVTHLTRSLR	SPAG5	1066	Q96R06
RSVASRTLVRDLHLS	SMCHD1	1506	A6NHR9
RINIEHALTFLRNRS	SYNE2	91	Q8WXH0
LHSTIPRATSQRLLR	TOGARAM2	156	Q6ZUX3
SLHLRSNSLRTIPVR	LRRTM3	161	Q86VH5
ALARVLRQLSDVARH	NHS	131	Q6T4R5
SLLRCTVNLDHSIRR	NKPD1	516	Q17RQ9
RLRDSHETIASLRAQ	KIFC3	236	Q9BVG8
RVSRAFRSLVQLHLA	FBXL15	46	Q9H469
ADSTLLAISRHLRDV	FBXL12	216	Q9NXK8
GQAHSISLVRNRRII	LAMA1	2581	P25391
RGLRRQVSASELHTS	EPPK1	2711	P58107
RGLRRQVSASELHTS	EPPK1	3776	P58107
HDALLRAQSRQRSLL	PPP1R16A	321	Q96I34
NRLTFASTLSHLRRL	POLR2B	471	P30876
NEIAHTRLRASTRDL	SIPA1L1	1511	O43166
RRFEVSSSLILRNHN	SETMAR	471	Q53H47
REIRHIRNSSVRTKL	SETX	326	Q7Z333
RGDRTVLVIAHRLQT	TAP2	651	Q03519
LRVIAHSSIQRILRN	ST6GALNAC5	141	Q9BVH7
GRLLRASVARHVSAI	PRDX3	6	P30048
HARRNVFDLVRTLRV	WHRN	66	Q9P202
SSHIQVLARRKSREI	TEAD2	101	Q15562
TVALHSIRRISCRSL	SNPH	466	O15079
RHRLSRRVLLEVATA	SRCAP	966	Q6ZRS2
IRRRLSEQLAHTPTA	PI4KB	506	Q9UBF8
AVVEETRALRSRIHL	STXBP4	341	Q6ZWJ1
TRALRSRIHLAEAAQ	STXBP4	346	Q6ZWJ1
RELRRLGITHVLNAS	DUSP26	81	Q9BV47
RRTFETARHNLIINI	SGCE	136	O43556
NRTSVDLRIRRTQHS	STX2	106	P32856
DLRIRRTQHSVLSRK	STX2	111	P32856
RLARLLGVHTQTRAA	SMARCD2	316	Q92925
HGLIRESLQVVRSRD	CHST2	346	Q9Y4C5
VGQRRTLLRHILVSD	CHST14	131	Q8NCH0
RLASILTSAARLVNH	COASY	21	Q13057
LNERVHRVRALQSTL	CNKSR1	616	Q969H4
SASEVLTRHLLQRRL	C15orf61	31	A6NNL5
ARERSRVQTLRHAFL	TCF24	56	Q7RTU0
RVQTLRHAFLELQRT	TCF24	61	Q7RTU0
LRRSQAAASHRVLQR	PDCD11	1736	Q14690
DLATALHRLSLRRQN	TRAK2	481	O60296
SLIHATLRRNNREAT	TULP4	981	Q9NRJ4
QARATVILHAVRIDR	UNC45B	211	Q8IWX7
RHLLQVRRSSSVAQV	UBD	101	O15205
ARRSHSALLAALTVL	XYLT1	11	Q86Y38
HDVLARSRSRANVLN	TMEM9B	156	Q9NQ34
LLSVLRESHRSRTVF	WDFY3	631	Q8IZQ1
RLLTVVRRANSSEQH	WDFY3	1121	Q8IZQ1
VVRSFLHARLRTATL	PSMD3	226	O43242
ERLARSQIHSIRDLQ	PDGFA	31	P04085
NLTLISVELHARTRR	REV3L	2296	O60673
NVRSQILRLRHTAFV	MRPS9	41	P82933
VRSHESLRATLQRAP	SPEG	511	Q15772
ARQIDRSHCSRILLL	STAG3	916	Q9UJ98
LLVLTATSHQERRAQ	SLC25A45	81	Q8N413
RITLLRGNHESRQIT	PPP6C	106	O00743
RRLSLHVLSATQAER	SEMA3B	656	Q13214
RINVAVTRARRHVAV	IGHMBP2	596	P38935
LLTATVASRIHRAAQ	SPPL3	326	Q8TCT6
NDISHRLRLSAVRLQ	VSTM2B	106	A6NLU5
ASLSEALSLIHRRRA	WDR97	806	A6NE52
IRTLAAERHARLNDS	SPTAN1	346	Q13813
TTSLVLERSLNRVHL	SSBP1	21	Q04837
LRDTANRLRIHSIRA	TKTL2	16	Q9H0I9
DRRHLVLSSGTLRIS	PXDN	476	Q92626
RHRVHLRSATLRDAV	RNASEH2C	11	Q8TDP1
AVEQLRTHTRRLSAL	SRPRA	461	P08240
RLARHSLESATRVLE	RPAP1	571	Q9BWH6
SELTVLRLSHNRIQL	TLR6	76	Q9Y2C9
RRDLRRTHALLSDVQ	MYO18B	1801	Q8IUG5
HVLERLQSESLVNRR	ZNF350	86	Q9GZX5
LLASASRDRLIHVLN	WDR62	551	O43379
AVLTHTLLRAARAAR	TMEM221	166	A6NGB7
SRIFTSDRLLVHQRS	ZNF474	291	Q6S9Z5
NSIRSLAIRVSVHSL	SCN11A	116	Q9UI33
RRFTLRSSLREHLQI	ZBTB2	261	Q8N680
RVTVDRSTIARHLLS	UBE4A	1011	Q14139
VRSINHASLISALSR	XPO6	746	Q96QU8
ISVISHLTKRRRSQR	TMIGD3	226	P0DMS9
LVVALVAERFARRTH	SLC30A1	51	Q9Y6M5
DRITLIRGNHESRQI	PPP4C	106	P60510
SDISLVGSHRRVRLN	C16orf82	161	Q7Z2V1
IRDALRSILTISRHG	MARS1	701	P56192
ASRHVARNLLRLLTS	WDR81	1241	Q562E7
RTDSRLVRSILTAHG	TTLL5	71	Q6EMB2
RLIESLRNSHSSIAE	VPS37A	31	Q8NEZ2
RSFRTSSNLVIHRRI	ZNF692	396	Q9BU19
SLRVLNRHFSQDLTR	TMPRSS6	91	Q8IU80
SSTVHILSQLLRLRQ	TTF2	911	Q9UNY4
TAHRRLLISADRRSV	RNF39	236	Q9H2S5
INVTSASLLIHSLRR	TAS2R4	191	Q9NYW5
HRDLLRRIVSSIVHQ	ZNF541	271	Q9H0D2
TEIAFLQTHRLLRQR	MYOM3	111	Q5VTT5
TDTILFIRAARRVHS	MYBPC3	1026	Q14896